EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Lishu Zhao iD, Jianxian Ge, Ruru Zhang, Hao Wang, Xinyue Liu, Kandi Xu, Yujin Liu, Wencheng Zhao, Wengang Zhang, Li Ye, Zhimin Chen, Jianfeng Zeng und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202404231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Lishu Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University…. Hauptthemen laut MEDLINE: Lymphocyte Activation Gene 3 Protein, Lung Neoplasms, B7-H1 Antigen, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has significantly improved cancer patient survival, while its efficacy remains limited due to the reliance on a single marker like PD‐L1 as well as its spatiotemporal heterogeneity. To address this issue, combining lymphocyte activation gene‐3 (LAG‐3) with PD‐L1 is proposed for identifying immunotypes and monitoring immunotherapy through nuclear imaging. In short, 99m Tc‐HYNIC‐αLAG‐3 and 99m Tc‐HYNIC‐αPD‐L1 probes are synthesized using anti‐human LAG‐3 and PD‐L1 antibodies, respectively. With high radiochemical purity and in vitro stability, these probes are confirmed to specifically bind to LAG‐3 or PD‐L1 in LAG3 + A549, LAG3 − A549, and H1975 cells. SPECT/CT imaging of both probes showed specific in vivo tumor uptake in multiple lung cancer models, with significant linear correlation with ex vivo tumor uptake and immunohistochemical expression levels of LAG‐3/PD‐L1. Based on this, dual‐index imaging was performed to simultaneously quantify LAG‐3 and PD‐L1. SPECT/CT imaging of 99m Tc‐HYNIC‐αLAG‐3 and 125 I‐αPD‐L1 successfully distinguished four immunotypes. In addition, SPECT/CT imaging revealed LAG‐3 upregulation in LLC‐bearing LAG‐3 humanized mice resistant to immunotherapy. In conclusion, this study demonstrates the feasibility of nuclear imaging of LAG‐3 and PD‐L1 for both noninvasive immunotyping and immunotherapy monitoring, thus offering novel perspectives on forecasting immunotherapy response, uncovering resistance mechanism, and optimizing combination treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte Activation Gene 3 ProteinLung NeoplasmsB7-H1 AntigenImmunotherapyAntigens, CDAnimalsMiceHumansCell Line, TumorDisease Models, Animal

Stichwörter der Autor:innen

LAG‐3PD‐L1SPECTimmunotherapyimmunotypelung cancernuclear imaging

Substanzen

Lymphocyte Activation Gene 3 ProteinB7-H1 AntigenAntigens, CDLag3 protein, humanCD274 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University, No 507 Zhengmin Road, Shanghai, 200433, China.
  • Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation…

ORCID-Profile: Lishu Zhao, Yayi He

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Science and Technology Major Project
  • Fundamental Research Funds for the Central Universities
  • Shanghai Municipal Health Commission Health Industry Clinical Research Project
  • Clinical Research Project of Shanghai Pulmonary Hospital
  • Young Talents in Shanghai
  • Shanghai Shuguang Scholar
  • 2021 Science and Technology Think Tank Youth Talent Plan of China Association for Science and Technology

Zitieren

APA

Zhao, L., Ge, J., Zhang, R., Wang, H., Liu, X., Xu, K., Liu, Y., Zhao, W., Zhang, W., Ye, L., Chen, Z., Zeng, J., He, Y., & Gao, M. (2025). Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1. Advanced Science. https://doi.org/10.1002/advs.202404231

Vancouver

Zhao L, Ge J, Zhang R, Wang H, Liu X, Xu K, et al. Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1. Advanced Science. 2025. doi:10.1002/advs.202404231

BibTeX
@article{Zhao2025,
  author = {Zhao, Lishu and Ge, Jianxian and Zhang, Ruru and Wang, Hao and Liu, Xinyue and Xu, Kandi and Liu, Yujin and Zhao, Wencheng and Zhang, Wengang and Ye, Li and Chen, Zhimin and Zeng, Jianfeng and He, Yayi and Gao, Mingyuan},
  title = {Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202404231}
}
Kostenlos starten →